<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Template%3ACommon_Anti-hyperglycemic_Drugs_and_Pharmacology</id>
	<title>Template:Common Anti-hyperglycemic Drugs and Pharmacology - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Template%3ACommon_Anti-hyperglycemic_Drugs_and_Pharmacology"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:Common_Anti-hyperglycemic_Drugs_and_Pharmacology&amp;action=history"/>
	<updated>2026-04-21T02:44:50Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Template:Common_Anti-hyperglycemic_Drugs_and_Pharmacology&amp;diff=372365&amp;oldid=prev</id>
		<title>Rossdonaldson1: /* Common Anti-hyperglycemic Drugs and Pharmacology */</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:Common_Anti-hyperglycemic_Drugs_and_Pharmacology&amp;diff=372365&amp;oldid=prev"/>
		<updated>2024-01-31T20:56:46Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Common Anti-hyperglycemic Drugs and Pharmacology&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 20:56, 31 January 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l33&quot;&gt;Line 33:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 33:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| 12-24h&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| 12-24h&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;See also [[GLP-1 agonists]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Rossdonaldson1</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Template:Common_Anti-hyperglycemic_Drugs_and_Pharmacology&amp;diff=133633&amp;oldid=prev</id>
		<title>Lisayee25: /* Common Anti-hyperglycemic Drugs and Pharmacology */</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:Common_Anti-hyperglycemic_Drugs_and_Pharmacology&amp;diff=133633&amp;oldid=prev"/>
		<updated>2017-05-05T03:49:30Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Common Anti-hyperglycemic Drugs and Pharmacology&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 03:49, 5 May 2017&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l18&quot;&gt;Line 18:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 18:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| 6-10h&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| 6-10h&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| &amp;lt;strong&amp;gt;Intermediate-acting insulin&amp;lt;/strong&amp;gt;&amp;lt;/p&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;NPH&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| &amp;lt;strong&amp;gt;Intermediate-acting insulin&amp;lt;/strong&amp;gt;&amp;lt;/p&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;NPH &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(Humulin, Novolin)&lt;/ins&gt;&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| 1-3h&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| 1-3h&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| 4-12h&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| 4-12h&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Lisayee25</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Template:Common_Anti-hyperglycemic_Drugs_and_Pharmacology&amp;diff=74690&amp;oldid=prev</id>
		<title>Rossdonaldson1: Created page with &quot;===Common Anti-hyperglycemic Drugs and Pharmacology=== {| class=&quot;wikitable&quot; !  rowspan=&quot;2&quot; | Drug !  colspan=&quot;3&quot; | Pharmacology |-  ! Onset ! Peak ! Duration |-  | &lt;strong&gt;Rap...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:Common_Anti-hyperglycemic_Drugs_and_Pharmacology&amp;diff=74690&amp;oldid=prev"/>
		<updated>2016-06-09T07:45:48Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;===Common Anti-hyperglycemic Drugs and Pharmacology=== {| class=&amp;quot;wikitable&amp;quot; !  rowspan=&amp;quot;2&amp;quot; | Drug !  colspan=&amp;quot;3&amp;quot; | Pharmacology |-  ! Onset ! Peak ! Duration |-  | &amp;lt;strong&amp;gt;Rap...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;===Common Anti-hyperglycemic Drugs and Pharmacology===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
!  rowspan=&amp;quot;2&amp;quot; | Drug&lt;br /&gt;
!  colspan=&amp;quot;3&amp;quot; | Pharmacology&lt;br /&gt;
|- &lt;br /&gt;
! Onset&lt;br /&gt;
! Peak&lt;br /&gt;
! Duration&lt;br /&gt;
|- &lt;br /&gt;
| &amp;lt;strong&amp;gt;Rapid-acting insulin&amp;lt;/strong&amp;gt;&amp;lt;/p&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;Aspart (Novolog)&amp;lt;/li&amp;gt;&amp;lt;li&amp;gt;Lispro (Humalog)&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&lt;br /&gt;
| 15-30min&lt;br /&gt;
| 1-2h&lt;br /&gt;
| 3-5h&lt;br /&gt;
|- &lt;br /&gt;
| &amp;lt;strong&amp;gt;Short-acting insulin&amp;lt;/strong&amp;gt;&amp;lt;/p&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;Regular&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&lt;br /&gt;
| 30-60min&lt;br /&gt;
| 2-4h&lt;br /&gt;
| 6-10h&lt;br /&gt;
|- &lt;br /&gt;
| &amp;lt;strong&amp;gt;Intermediate-acting insulin&amp;lt;/strong&amp;gt;&amp;lt;/p&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;NPH&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&lt;br /&gt;
| 1-3h&lt;br /&gt;
| 4-12h&lt;br /&gt;
| 18-24h&lt;br /&gt;
|- &lt;br /&gt;
| &amp;lt;strong&amp;gt;Long-acting insulin&amp;lt;/strong&amp;gt;&amp;lt;/p&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;Glargine (Lantus)&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&lt;br /&gt;
| 2-4h&lt;br /&gt;
| None&lt;br /&gt;
| 24h&lt;br /&gt;
|- &lt;br /&gt;
| &amp;lt;strong&amp;gt;Sulfonylurea&amp;lt;/strong&amp;gt;&amp;lt;/p&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;Glimepiride&amp;lt;/li&amp;gt;&amp;lt;li&amp;gt;Glipizide (Glucotrol)&amp;lt;/li&amp;gt;&amp;lt;li&amp;gt;Glyburide (Glycron, Micronase)&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&lt;br /&gt;
| &amp;amp;#8211;&lt;br /&gt;
| 2-6h&lt;br /&gt;
| 12-24h&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Rossdonaldson1</name></author>
	</entry>
</feed>